Shattuck Labs, Inc.
STTK • NASDAQ
Shattuck Labs, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Taylor H. Schreiber, with a market cap of $225.9M.
CEOTaylor H. Schreiber
Market Cap$225.9M
Biotechnology
Healthcare
Employees75.0
Websiteshattucklabs.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Shattuck Labs, Inc.
Date
Thursday, April 30, 2026 (in 3 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.12
Earnings History
Past 11 earnings reports for Shattuck Labs, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 6, 2025 | Q3 2025 | -$0.14Est: -$0.15 | +6.7% | $1.0M | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.24Est: -$0.25 | +4.0% | - | — | 10-Q |
| May 1, 2025 | Q1 2025 | -$0.27Est: -$0.23 | -17.4% | - | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.37Est: -$0.32 | -15.6% | -Est: $999.3K | -100.0% | 10-K/A |
| Nov 14, 2024 | Q3 2024 | -$0.33Est: -$0.42 | +21.4% | $3.0MEst: $650.0K | +361.1% | 10-Q |
| Aug 1, 2024 | Q2 2024 | -$0.42Est: -$0.41 | -2.4% | $1.6MEst: $660.0K | +143.8% | 10-Q |
| May 2, 2024 | Q1 2024 | -$0.37Est: -$0.45 | +17.8% | $1.1MEst: $230.0K | +384.8% | 10-Q |
| Feb 29, 2024 | Q4 2023 | -$0.41Est: -$0.57 | +28.1% | $714.0KEst: $200.0K | +257.0% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.65Est: -$0.52 | -25.0% | $686.0KEst: $180.0K | +281.1% | — |
| Aug 10, 2023 | Q2 2023 | -$0.50Est: -$0.52 | +3.8% | $200.0KEst: $100.0K | +100.0% | — |
| May 9, 2023 | Q1 2023 | -$0.49Est: -$0.63 | +22.2% | $57.0KEst: $80.0K | -28.7% | — |